| 1 |
Lei M, Zhang L, Lei J, Zong L, Li J, Wu Z, et al. Overview of emerging contaminants and associated human health effects. Biomed Res Int 2015;2015:404796.
|
| 2 |
Pereira LC, de Souza AO, Franco Bernardes MF, Pazin M, Tasso MJ, Pereira PH, et al. A perspective on the potential risks of emerging contaminants to human and environmental health. Environ Sci Pollut Res Int 2015;22:13800-23.
DOI
|
| 3 |
Vrijheid M, Casas M, Gascon M, Valvi D, Nieuwenhuijsen M. Environmental pollutants and child health - a review of recent concerns. Int J Hyg Environ Health 2016;219:331-42.
DOI
|
| 4 |
Giesy JP, Kannan K. Perfluorochemical surfactants in the environment. Environ Sci Technol 2002;36:146A-52A.
DOI
|
| 5 |
Peden-Adams MM, Keller JM, Eudaly JG, Berger J, Gilkeson GS, Keil DE. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicol Sci 2008;104:144-54.
DOI
|
| 6 |
Guruge KS, Hikono H, Shimada N, Murakami K, Hasegawa J, Yeung LW, et al. Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. J Toxicol Sci 2009;34:687-91.
DOI
|
| 7 |
Kato K, Wong LY, Jia LT, Kuklenyik Z, Calafat AM. Trends in exposure to polyfluoroalkyl chemicals in the U.S. Population: 1999-2008. Environ Sci Technol 2011;45:8037-45.
DOI
|
| 8 |
Lau C, Thibodeaux JR, Hanson RG, Narotsky MG, Rogers JM, Lindstrom AB, et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 2006;90:510-8.
DOI
|
| 9 |
Morikawa A, Kamei N, Harada K, Inoue K, Yoshinaga T, Saito N, et al. The bioconcentration factor of perfluorooctane sulfonate is significantly larger than that of perfluorooctanoate in wild turtles (Trachemys scripta elegans and Chinemys reevesii): an Ai river ecological study in Japan. Ecotoxicol Environ Saf 2006;65:14-21.
DOI
|
| 10 |
Harada KH, Yang HR, Moon CS, Hung NN, Hitomi T, Inoue K, et al. Levels of perfluorooctane sulfonate and perfluorooctanoic acid in female serum samples from Japan in 2008, Korea in 1994-2008 and Vietnam in 2007-2008. Chemosphere 2010;79:314-9.
DOI
|
| 11 |
Karrman A, Ericson I, van Bavel B, Darnerud PO, Aune M, Glynn A, et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 2007;115:226-30.
DOI
|
| 12 |
Lee YJ, Kim MK, Bae J, Yang JH. Concentrations of perfluoroalkyl compounds in maternal and umbilical cord sera and birth outcomes in Korea. Chemosphere 2013;90:1603-9.
DOI
|
| 13 |
Kannan K, Corsolini S, Falandysz J, Fillmann G, Kumar KS, Loganathan BG, et al. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environ Sci Technol 2004;38:4489-95.
DOI
|
| 14 |
Giesy JP, Kannan K. Global distribution of perfluorooctane sulfonate in wildlife. Environ Sci Technol 2001;35:1339-42.
DOI
|
| 15 |
Martin JW, Mabury SA, Solomon KR, Muir DC. Bioconcentration and tissue distribution of perfluorinated acids in rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 2003;22:196-204.
DOI
|
| 16 |
Hansen KJ, Clemen LA, Ellefson ME, Johnson HO. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ Sci Technol 2001;35:766-70.
DOI
|
| 17 |
D'Hollander W, de Voogt P, De Coen W, Bervoets L. Perfluorinated substances in human food and other sources of human exposure. Rev Environ Contam Toxicol 2010;208:179-215.
|
| 18 |
Martin JW, Mabury SA, Solomon KR, Muir DC. Dietary accumulation of perfluorinated acids in juvenile rainbow trout (Oncorhynchus mykiss). Environ Toxicol Chem 2003;22:189-95.
DOI
|
| 19 |
Conder JM, Hoke RA, De Wolf W, Russell MH, Buck RC. Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds. Environ Sci Technol 2008;42:995-1003.
DOI
|
| 20 |
Olsen GW, Chang SC, Noker PE, Gorman GS, Ehresman DJ, Lieder PH, et al. A comparison of the pharmacokinetics of perfluorobutanesulfonate(PFBS) in rats, monkeys, and humans. Toxicology 2009;256:65-74.
DOI
|
| 21 |
Olsen GW, Huang HY, Helzlsouer KJ, Hansen KJ, Butenhoff JL, Mandel JH. Historical comparison of perfluorooctanesulfonate, perfluorooctanoate, and other fluorochemicals in human blood. Environ Health Perspect 2005;113:539-45.
DOI
|
| 22 |
Fei C, McLaughlin JK, Lipworth L, Olsen J. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect 2008;116:1391-5.
DOI
|
| 23 |
Forns J, Iszatt N, White RA, Mandal S, Sabaredzovic A, Lamoree M, et al. Perfluoroalkyl substances measured in breast milk and child neuropsychological development in a Norwegian birth cohort study. Environ Int 2015;83:176-82.
DOI
|
| 24 |
Grandjean P, Andersen EW, Budtz-Jorgensen E, Nielsen F, Molbak K, Weihe P, et al. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA 2012;307:391-7.
|
| 25 |
Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Budtz-Jorgensen E. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ Health Perspect 2017;125:077018.
DOI
|
| 26 |
Granum B, Haug LS, Namork E, Stolevik SB, Thomsen C, Aaberge IS, et al. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol 2013;10:373-9.
DOI
|
| 27 |
Donauer S, Chen A, Xu Y, Calafat AM, Sjodin A, Yolton K. Prenatal exposure to polybrominated diphenyl ethers and polyfluoroalkyl chemicals and infant neurobehavior. J Pediatr 2015;166:736-42.
DOI
|
| 28 |
Chen MH, Ha EH, Liao HF, Jeng SF, Su YN, Wen TW, et al. Perfluorinated compound levels in cord blood and neurodevelopment at 2 years of age. Epidemiology 2013;24:800-8.
DOI
|
| 29 |
Goudarzi H, Nakajima S, Ikeno T, Sasaki S, Kobayashi S, Miyashita C, et al. Prenatal exposure to perfluorinated chemicals and neurodevelopment in early infancy: the Hokkaido Study. Sci Total Environ 2016;541:1002-10.
DOI
|
| 30 |
Stein CR, Savitz DA, Bellinger DC. Perfluorooctanoate and neuropsychological outcomes in children. Epidemiology 2013;24:590-9.
DOI
|
| 31 |
Wang Y, Rogan WJ, Chen HY, Chen PC, Su PH, Chen HY, et al. Prenatal exposure to perfluroalkyl substances and children's IQ: The Taiwan maternal and infant cohort study. Int J Hyg Environ Health 2015;218:639-44.
DOI
|
| 32 |
Stein CR, Savitz DA. Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5-18 years of age. Environ Health Perspect 2011;119:1466-71.
DOI
|
| 33 |
Fei C, Olsen J. Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years. Environ Health Perspect 2011;119:573-8.
DOI
|
| 34 |
Buser MC, Scinicariello F. Perfluoroalkyl substances and food allergies in adolescents. Environ Int 2016;88:74-9.
DOI
|
| 35 |
Goudarzi H, Miyashita C, Okada E, Kashino I, Chen CJ, Ito S, et al. Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4 years of age. Environ Int 2017;104:132-8.
DOI
|
| 36 |
Timmermann CA, Budtz-Jorgensen E, Jensen TK, Osuna CE, Petersen MS, Steuerwald U, et al. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination. J Immunotoxicol 2017;14:39-49.
DOI
|
| 37 |
Kielsen K, Shamim Z, Ryder LP, Nielsen F, Grandjean P, Budtz-Jorgensen E, et al. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J Immunotoxicol 2016;13:270-3.
DOI
|
| 38 |
Lee YJ, Park SJ, Yang JH. Perfluorooctanesulfonate (PFOS) activates mast cell-mediated allergic reaction. Organohalogen Compd 2017;79:718-21.
|
| 39 |
Olsen GW, Church TR, Hansen KJ, Burris JM, Butenhoff JL, Mandel JH, et al. Quantitative evaluation of perfluorooctanesulfonate(PFOS) and other fluorochemicals in the serum of children. J Child Health 2004;2:53-76.
DOI
|
| 40 |
Calafat AM, Wong LY, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 2007;115:1596-602.
DOI
|
| 41 |
Toms LM, Calafat AM, Kato K, Thompson J, Harden F, Hobson P, et al, Mueller JF. Polyfluoroalkyl chemicals in pooled blood serum from infants, children, and adults in Australia. Environ Sci Technol 2009;43:4194-9.
DOI
|
| 42 |
Darrow LA, Groth AC, Winquist A, Shin HM, Bartell SM, Steenland K. Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a Mid-Ohio Valley Community. Environ Health Perspect 2016;124:1227-33.
DOI
|
| 43 |
Dhingra R, Lally C, Darrow LA, Klein M, Winquist A, Steenland K. Perfluorooctanoic acid and chronic kidney disease: Longitudinal analysis of a Mid-Ohio Valley community. Environ Res 2016;145:85-92.
DOI
|
| 44 |
Steenland K, Zhao L, Winquist A, Parks C. Ulcerative colitis and perfluorooctanoic acid (PFOA) in a highly exposed population of community residents and workers in the mid-Ohio valley. Environ Health Perspect 2013;121:900-5.
DOI
|
| 45 |
Winquist A, Lally C, Shin HM, Steenland K. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers. Environ Health Perspect 2013;121:893-9.
DOI
|
| 46 |
Hoyer BB, Ramlau-Hansen CH, Obel C, Pedersen HS, Hernik A, Ogniev V, et al. Pregnancy serum concentrations of perfluorinated alkyl substances and offspring behaviour and motor development at age 5-9 years--a prospective study. Environ Health 2015;14:2.
DOI
|
| 47 |
WHO Regional Office for Europe. Keeping our water clean: the case of water contamination in the Veneto Region, Italy [Internet]. Copenhagen: WHO Regional Office for Europe; 2017 [cited 2018 October 31]. http://www.euro.who.int/__data/assets/pdf_file/0019/341074/pfas-report-20170606-h1330-print-isbn.pdf?ua=1
|
| 48 |
Vuong AM, Yolton K, Webster GM, Sjodin A, Calafat AM, Braun JM, et al. Prenatal polybrominated diphenyl ether and perfluoroalkyl substance exposures and executive function in school-age children. Environ Res 2016;147:556-64.
DOI
|
| 49 |
Harris MH, Oken E, Rifas-Shiman SL, Calafat AM, Ye X, Bellinger DC, et al. Prenatal and childhood exposure to perand polyfluoroalkyl substances (PFASs) and child cognition. Environ Int 2018;115:358-69.
DOI
|
| 50 |
Lien GW, Huang CC, Shiu JS, Chen MH, Hsieh WS, Guo YL, et al. Perfluoroalkyl substances in cord blood and attention deficit/hyperactivity disorder symptoms in seven-yearold children. Chemosphere 2016;156:118-27.
DOI
|
| 51 |
Liew Z, Ritz B, von Ehrenstein OS, Bech BH, Nohr EA, Fei C, et al. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort. Environ Health Perspect 2015;123:367-73.
DOI
|
| 52 |
Ode A, Kallen K, Gustafsson P, Rylander L, Jönsson BA, Olofsson P, et al. Fetal exposure to perfluorinated compounds and attention deficit hyperactivity disorder in childhood. PLoS One 2014;9:e95891.
DOI
|
| 53 |
Bolin CM, Basha R, Cox D, Zawia NH, Maloney B, Lahiri DK, et al. Exposure to lead and the developmental origin of oxidative DNA damage in the aging brain. FASEB J 2006;20:788-90.
DOI
|
| 54 |
Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, et al. Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD. J Neurosci 2008;28:3-9.
DOI
|
| 55 |
Johansson N, Fredriksson A, Eriksson P. Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology 2008;29:160-9.
DOI
|
| 56 |
Fox DA, Grandjean P, de Groot D, Paule MG. Developmental origins of adult diseases and neurotoxicity: epidemiological and experimental studies. Neurotoxicology 2012;33:810-6.
DOI
|
| 57 |
Mastrantonio M, Bai E, Uccelli R, Cordiano V, Screpanti A, Crosignani P. Drinking water contamination from perfluoroalkyl substances (PFAS): an ecological mortality study in the Veneto Region, Italy. Eur J Public Health 2018;28:180-5.
DOI
|
| 58 |
Johansson N, Eriksson P, Viberg H. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicol Sci 2009;108:412-8.
DOI
|
| 59 |
Lee I, Viberg H. A single neonatal exposure to perfluorohexane sulfonate (PFHxS) affects the levels of important neuroproteins in the developing mouse brain. Neurotoxicology 2013;37:190-6.
DOI
|
| 60 |
Viberg H, Lee I, Eriksson P. Adult dose-dependent behavioral and cognitive disturbances after a single neonatal PFHxS dose. Toxicology 2013;304:185-91.
DOI
|
| 61 |
Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology 2002;23:659-68.
DOI
|
| 62 |
Lee HG, Lee YJ, Yang JH. Perfluorooctane sulfonate induces apoptosis of cerebellar granule cells via a ROS-dependent protein kinase C signaling pathway. Neurotoxicology 2012;33:314-20.
DOI
|
| 63 |
Lee YJ, Lee HG, Yang JH. Perfluorooctane sulfonate-induced apoptosis of cerebellar granule cells is mediated by ERK 1/2 pathway. Chemosphere 2013;90:1597-602.
DOI
|
| 64 |
Dunlop J, Matsui E, Sharma HP. Allergic rhinitis: environmental determinants. Immunol Allergy Clin North Am 2016;36:367-77.
DOI
|
| 65 |
Lee YJ, Choi SY, Yang JH. PFHxS induces apoptosis of neuronal cells via ERK1/2-mediated pathway. Chemosphere 2014;94:121-7.
DOI
|
| 66 |
Lee YJ, Choi SY, Yang JH. NMDA receptor-mediated ERK 1/2 pathway is involved in PFHxS-induced apoptosis of PC12 cells. Sci Total Environ 2014;491-2:227-34.
|
| 67 |
Lee YJ, Choi SY, Yang JH. AMP-activated protein kinase is involved in perfluorohexanesulfonate-induced apoptosis of neuronal cells. Chemosphere 2016;149:1-7.
DOI
|
| 68 |
Yang SN, Hsieh CC, Kuo HF, Lee MS, Huang MY, Kuo CH, et al. The effects of environmental toxins on allergic inflammation. Allergy Asthma Immunol Res 2014;6:478-84.
DOI
|
| 69 |
Takano H, Inoue KI. Environmental pollution and allergies. J Toxicol Pathol 2017;30:193-9.
DOI
|
| 70 |
Holladay SD, Smialowicz RJ. Development of the murine and human immune system: differential effects of immunotoxicants depend on time of exposure. Environ Health Perspect 2000;108(Suppl 3):463-73.
|
| 71 |
Martino D, Prescott S. Epigenetics and prenatal influences on asthma and allergic airways disease. Chest 2011;139:640-7.
DOI
|
webmaster
